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Thousands of chemicals have been identified as contaminants of emerging concern (CECs), but prioritizing
them concerning ecological and human health risks is challenging.We explored the use of sewage treatment
plants as chemical observatories to conveniently identify persistent and bioaccumulative CECs, including
toxic organohalides. Nationally representative samples of sewage sludge (biosolids) were analyzed for 231
CECs, of which 123 were detected. Ten of the top 11 most abundant CECs in biosolids were found to be
high-production volume chemicals, eight of which representing priority chemicals, including three flame
retardants, three surfactants and two antimicrobials. A comparison of chemicals detected in nationally
representative biological specimens from humans and municipal biosolids revealed 70% overlap. This
observed co-occurrence of contaminants in both matrices suggests that the analysis of sewage sludge can
inform human health risk assessments by providing current information on toxic exposures in human
populations and associated body burdens of harmful environmental pollutants.
T
housands of organic chemicals have been identified as contaminants of emerging concern (CECs)1.
Sampling and identification of CECs in various environmental matrices for prioritization of CECs is often
time consuming, tedious, and costly. Hence, several methods of screening for potential CECs have been
proposed1–7. Screening methods typically consider the persistence, bioaccumulation potential and toxicity of
chemicals (PBT approach). However, this approach does not consider two critical aspects influencing the risks
posed by chemicals to humans and ecosystems: current chemical production rates and the individual behavior of
chemicals in real-world biological systems. Tools informing on chemical usage rates and real-world biodegrad-
ability of chemicals thus would be a welcome addition to the toolbox of risk assessors tasked with prioritizing and
managing CECs. Most chemicals used in consumer products are ultimately washed down the drain and are
collected in municipal sewers (Fig. 1). Efficient chemical monitoring at wastewater treatment plants (WWTPs)
thusmay provide up-to-date information on chemical usage rates for epidemiological assessments. This so-called
‘‘sewage epidemiology’’ approach has been employed by other researchers to evaluate illicit-drug use in com-
munities via measurement of drug levels in influent wastewater8–10. Here, we demonstrate the use of sample
repositories from U.S. WWTPs nationwide to conveniently derive information on the occurrence and identity of
CECs as well as their bioaccumulation potential and propensity to withstand degradation processes. The under-
lying hypothesis of this work is that WWTPs can serve as chemical observatories to study the prevalence and
likely fate of chemicals and their bioaccumulation potential in human society and the environment.
Secondary treatment of municipal sewage consists of a biological treatment operation employing a highly
complex and concentrated microbial community. Chemicals managing to withstand unscathed the passage
through primary and secondary WWTP unit operations have to be considered notably resistant to aerobic
degradation processes (which typically are employed in secondary treatment) and thus may have the potential
to also persist in the environment upon release. Biosolids, i.e., treated municipal sludge fit for application on land
are known to represent a ‘sink’ for hydrophobic organic compounds of limited biodegradability. Hundreds of
organic chemicals including polychlorinated biphenyls (PCBs), brominated flame retardants (BFRs) and specific
pharmaceuticals and personal care products (PPCPs), such as polychlorinated aromatic antimicrobials have been
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proposed for predicting chemical loading to WWTPs and for iden-
tifying potentially problematic high-production volume (HPV) che-
micals based on the fraction sorbed to biosolids18–20. In the present
study, we explore the use of municipal biosolids as an analytical
matrix to identify hydrophobic CECs potentially posing a human
health threat based on chemical abundance, environmental persist-
ence, and bioaccumulation potential, as indicated by a lack of trans-
formation during aerobic and anaerobic digestion in modern
WWTPs, and subsequent accumulation in the carbon- and lipid-rich
biosolids which may serve as a proxy to the human body (Fig. 1).
Results
WWTPs as chemical observatories. A total of 123 chemicals were
detected in biosolids, of which the nationwide occurrence of 17
brominated chemicals in U.S. biosolids is reported here for the
first time (see Supplementary Table S9 online). The most abundant
group of chemicals in biosolids were alkylphenol surfactants (AP
and APEOs), followed by PPCPs and BFRs (Fig. 2a). Chemicals
monitored in biosolids in this study were calculated to contribute
about 0.04–0.15% of the total dry mass of biosolids produced in the
U.S. annually, a mass equivalent to 0.4–1.5 g/kg of dry sludge or a
total of 2,600–7,900 metric tonnes of chemicals annually. However,
this estimate likely is lower than the true value, since other organics
known to occur in biosolids (e.g., linear alkylbenzene sulfonates,
PCBs, etc.) were not included in this work. The study design
further excluded hundreds of hydrophilic compounds that, while
potentially being recalcitrant to the degradation processes, lack the
potential for sequestration in biosolids and accumulation in humans.
Most abundant CECs in biosolids. The top abundant individual
compounds detected in excess of 1000 mg/kg-dw composite bio-
solids samples emerging from the pool of 231 chemicals assayed
for include: BFRs [deca BDE-209, 1,2-bis(2,4,6-tribromophenoxy)
ethane (BTBPE), and penta-brominated BDE-99], surfactants
[nonylphenol (NP) and their ethoxylates (NPEOs)]; antimicrobials
(triclosan and triclocarban); and antibiotics (azithromycin, cipro-
floxacin, and ofloxacin) (Fig. 2b). BFRs are widely used in plastics,
textiles, electronics, and several household products to prevent fires.
The penta-BDE market was dominated by North America in the
1990s, and declined after these compounds were banned in Europe
in 200421–23. Since then the demand for deca-BDE increased and only
recently has been considered for regulation in the U.S.21. Although
BTBPE is considered to be a low-volume BFR andwas excluded from
EPA’s targeted national sewage sludge survey (TNSSS)12, it falls
under the category of highly abundant persistent chemicals list
using the present study approach. BFRs are known to persist and
bioaccumulate in the environment and also can be transformed to
other toxic chemicals, including brominated dioxins and furans (Br-
D/F)24. Br-D/F chemicals were also detected in the present study at
low levels (see Supplementary Table S9 online). The pathway by
which these compounds enter WWTPs is unclear, since BFR
containing products are not meant to be flushed or discharged
directly to the sewer. Their abundance in biosolids indicates an
alternative pathway or route of entry to the environment that must
be further studied. The surfactants and antimicrobials are known to
be of high production volume [HPV - compounds featuring an
annual usage volume in excess of 450,000 kg (1 million pounds)],
representing persistent CECs that have been widely detected in
various environmental matrices14,25–27. The three antibiotics
(azithromycin, ciprofloxacin, and ofloxacin) fall into the category
of highly abundant compounds, due to their extensive consump-
tion in the United States. Sales of ciprofloxacin in the U.S. were
already high at $1.97 billion in 2001 due to the anthrax scare28.
Azithromycin is also one of the world’s best selling antibiotics
according to online sources and its sales volume in the U.S. is
about $1.3 billion29. Although ciprofloxacin and ofloxacin have low
partition coefficients (Fig. 3), sorption to biosolids is driven by
electrostatic interactions with microorganisms in the sludge30,31.
These chemicals have also been widely detected in U.S. surface
water26,32 and their fate depends on environmental pH levels.
Human health concerns of antibiotics revolve primarily around
their ability to induce resistance to multiple drugs in microbial
pathogens. Buildup of antibiotics in the human body is a lesser
concern, since the antibiotics’ various polar moieties facilitate
rapid urinary excretion; however, recent studies show bioaccumu-
lation potential of antibiotics in macroorganisms33,34. Ciprofloxacin
was shown to be one of the most frequently detected antibiotics in
fish (muscle tissue) from the Haihe River in China33.
In general, the fate of chemicals in the environment is determined
by their partition coefficients and biodegradability. As noted above,
the environmental behavior of certain chemicals cannot be predicted
reliably from deterministic physical-chemical models. Idiosyncratic
structural features and biological interactions may result in chemical
fates which deviate substantially from those predicted from deter-
ministic models alone. The here presented approach for estimating
chemical fate from empirical observations made in actual biological
systems (secondary wastewater treatment and sludge digestion units)
thus may complement accepted contemporary approaches used in
Figure 1 | Fate and transport of anthropogenic chemicals through human society and the built wastewater environment (Courtesy: Arizona State
University).
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risk assessment. When utilizing this proposed diagnostic approach,
the secondary treatment step ofmunicipalWWTPs essentially serves
as a large-scale, aerobic preliminary biodegradability test for these
manmade chemicals, whereas treatment steps for excess sewage
sludge can serve to assess a chemical’s propensity to partition into
biota and resist anaerobic biodegradation processes.
Predicting consumption rates and environmental occurrence of
CECs. The estimated annual biosolids loads of the top most-
abundant chemicals detected in excess of 1000 mg/kg-dw (ppm) in
composite biosolids were compared with their respective production
volume in the U.S. (Fig. 2b). Between 0.1% and 48% of the individual
compounds’ production volume was found to be sequestered in bio-
solids. The highest percentage was determined for the antimicrobial
triclocarban, and the lowest was observed for one particular conge-
ner (BDE-99) of penta-brominated diphenylether flame retardants.
In addition, ten of the 11 most abundant compounds in biosolids
(detected . 1000 mg/kg-dw) are HPV chemicals; for the single
exception, the antibiotic ofloxacin (Fig. 2b), reliable production volu-
me estimates were unavailable. These high levels of sequestration in
sludge indicate the compound’s stability and persistence from its
production and use until disposal. The fact that 91% of the top 11
abundant compounds are HPV chemicals, indicate the integrity of
biosolids matrix in capturing hydrophobic chemicals relative to their
production volume. For example, the production of NP and NPEOs
exceeds the volume of other abundant chemicals by more than an
order of magnitude (see Supplementary Table S10 online), and these
Figure 2 | (a) Annualmass of U.S. biosolids and of emerging contaminants sequestered in biosolids followingmunicipal wastewater treatment, including
sludge digestion. Numbers in parenthesis represent the number of chemicals detected in each chemical group. Refer to the text for a definition of
acronyms used. (b) Occurrence in biosolids of chemicals detected in excess of 1000 mg/kg-dw and their corresponding annual U.S. production volumes.
Labels to the right identify primary chemical uses and the percentage of production mass that becomes sequestered in biosolids. Dotted vertical line
represents the annual production volume required forHPV classification (450,000 kg or 1millionU.S. pounds/year). Error bars represent the upper limit
of average biosolids load and production volume, respectively.
Figure 3 | Classification of 123 chemicals detected in biosolids based on
abundance in biosolids and on n-octanol water partition coefficient
(KOW). Numbers represent highly abundant chemicals: (1) BDE-209, (2)
BTBPE, (3) BDE-99, (4) NP, (5) NP1EO, (6) NP2EO, (7) triclocarban, (8)
triclosan, (9) azithromycin, (10) ciprofloxacin, (11) ofloxacin. The shaded
region in the top right is populated by priority CECs of high abundance
and high bioaccumulation potential.
www.nature.com/scientificreports
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two surfactants were the most abundant chemicals detected in
biosolids (Fig. 2a).
High chemical usage rates imply substantial chemical releases to
the environment and thus an increased risk of exposure for suscept-
ible receptors. Biosolids are known to be highly enriched in hydro-
phobic chemicals, which render them an ideal matrix for environ-
mentalmonitoring. Hydrophobic compounds detected in biosolids
in the parts-per-trillion (,1 mg/kg-dw) range are expected to fea-
ture very low environmental occurrences, good biodegradability,
or a combination of the two. In contrast, chemicals occurring in
biosolids in the parts-per-million (ppm) range (.1000 mg/kg-dw)
pose a potentially significant concern, due to high usage, resist-
ance to biodegradation and pronounced partitioning into bioso-
lids destined for application on land. Based on these established
facts, chemicals in biosolids may be prioritized in terms of poten-
tial environmental occurrence and risk by separating them into
three groups indicating low (,1) medium (1 – 1000) and high
(.1000) abundance in biosolids, expressed in units of mg/kg-dw
(Fig. 3). Among the 123 compounds detected in this survey of 231
analytes, 12 showed low abundance, 100 showed medium abund-
ance, and 11 featured high abundance. The selection of the ceiling
threshold of 1,000 mg/kg-dw is supported by European and U.S.
regulations that focus on compounds occurring in excess of 1 mg/
kg (ppm) in biosolids35. Since tracking of the present-day produc-
tion volume of chemicals used in commerce is difficult, ranking
chemical abundance (as high, medium, and low) from concentra-
tions detectable in process flows in WWTPs nationwide is a useful
tool and particularly promising for compounds that are disposed
of customarily into wastewater (e.g., triclocarban, an active ingre-
dient in antimicrobial soaps).
Predicting chemical body burden and bioaccumulation potential
of CECs. The national report on human exposure potential to
environmental chemicals by the Center of Disease Control and
Prevention (CDC) is one of the most comprehensive exposure
assessments of environmental chemicals in the U.S. population.
About 139 organic chemicals have been detected in human blood,
serum, urine, and tissue samples that represent the U.S. population36.
Chemical levels detected in humans reflect the amount of chemical
that actually gets into the body by all routes of exposure (ingestion,
inhalation, and dermal absorption)36. When combining the number
of chemicals detected in the present study with those detected in
EPA’s national sewage sludge surveys, a total of 187 organic che-
micals have been detected in nationwide representative biosolids
samples. Out of these, 52 chemicals have already been analyzed by
CDC, with 36 detects and 16 non-detects in human samples (Fig. 4a;
see Supplementary Table S11 online). That is, about 70% of
chemicals detected in biosolids were also detected in humans. The
16 non-detect chemicals were all detected in biosolids at levels
, 25 mg/kg-dw and fall into the categories of medium and low
abundance compounds, indicating lower consumption rates. Out
of the 36 detects, 34 chemicals were detected in human serum
samples, and two (triclosan and 1-hydroxypyrene) were detected
in urine samples. It is well established that the partitioning of
hydrophobic chemicals to sludge is due to their association with
the lipid fraction of microbial biomass37,38. This mechanism of
partitioning is similar to the way these chemicals bioaccumulate in
macroorganisms, wildlife and humans. Hence for comparison
purposes, the lipid-normalized concentrations of the 34 analytes
commonly detected in human serum and biosolids samples were
plotted against each other (Fig. 4b; see Supplementary Table S12
online). The plot revealed a linear trend (R2 5 0.62) suggesting a
similarity in the relative exposure to these chemicals by humans and
WWTPs. This relationship strengthens our hypothesis of using the
biosolids matrix as an indicator chemical exposure and body burden
in human populations, and suggests a need to investigate the
occurrence in humans of not previously monitored chemicals
detectable as persistent contaminants in biosolids.
The approach of biosolids analysis illustrated here additionally can
serve as an early warning system for potentially bioaccumulative
chemicals. Chemicals detected in biosolids were categorized as bioac-
cumulative based on the criterion set by the Stockholm Convention,
i.e., an n-octanol/water partitioning coefficient (KOW) of 105 or
greater. Using this approach, 55 chemicals were identified as being
potentially bioaccumulative; 93% of which were halogenated,
remarkably (Fig. 3). Also, 14 out of the 55 chemicals have already
been detected in human samples reported elsewhere39–42, thereby
emphasizing the need to assess the body burden, toxicity and risk
posed to human health by the remaining 31 chemicals. Of the 55
bioaccumulative chemicals, six were identified as highly abundant,
37 as havingmedium abundance and 12 as low-abundance chemicals
with respect to their detection levels in biosolids. The six highly
abundant chemicals included three BFRs and three surfactants
(BDE-99, BDE-209, BTBPE, NP, NP1EO, and NP2EO), which have
been shown to bioaccumulate in aquatic animals23,43–45. Although the
abundant antimicrobials triclosan and triclocarban do not quite sat-
isfy the criterion for bioaccumulation per se (log KOW of 4.9 for
triclocarban and 4.6 for triclosan), they are known to bioaccumulate
in aquatic organisms46,47. Hence, a total of eight abundant chemicals
(BDE-99, BDE-209, BTBPE, NP, NP1EO, NP2EO, triclosan and
triclocarban) are highlighted in Figure 3 as priority chemicals with
respect to both abundance and bioaccumulation potential.
Some of these chemicals have already been identified as priority
CECs in past studies that focused on similar prioritization effort6,7.
Triclosan was identified as one of the priority CECs in recycled water
systems using a similar science-based framework developed to
prioritize contaminants’ inclusion in reclaimed water monitoring
programs7. The authors used environmental concentrations and tox-
icological relevance of CECs to help in the prioritization effort.
Another study identified BTBPE and triclocarban among the top
10 (brominated and chlorinated, respectively) persistent and bioac-
cumulative (P&B) priority chemicals within a pool of 22,263 chemi-
cals from the Canadian Domestic Substance List (DSL) and U.S.
EPA’s Toxic Substances Control Act (TSCA) Inventory Update
Rule (IUR) database by using quantitative structure activity relation-
ship (QSAR)6. The top priority chemicals were selected based on the
production volume, bioconcentration factor and persistence of
CECs. Though these criteria for selection are similar to the present
study, the biosolids analysis approach additionally incorporates
environmentally relevant concentrations and fate of CECs in real-
world biological systems to identify priority chemicals. In addition, it
can convey important information on the actual persistence of che-
micals in environmental systems, as some chemicals may biodegrade
rapidly in the laboratory but fail to do so in field settings, where
sorption and a lack of bioavailability can impede attenuation.
Figure 3 additionally emphasizes the established fact that haloge-
nated compounds are more hydrophobic and lipophilic when com-
pared to non-halogenated compounds. This explains their dominan-
ce in the bioaccumulation region (Fig. 3; top right). It must also be
noted that out of the 36 chemicals detected in both humans and
biosolids samples (Fig. 4a), 35 chemicals (97%) were halogenated.
An analysis of the compounds included in the U.S. Safe Drinking
Water Act of the EPA shows that 74 percent of regulated organic
compounds carry one ormore halogen substituent48. It is well known
that the replacement of hydrogen with halogen atoms is positively
correlated with a chemical’s size, hydrophobicity, persistence and
toxicity49–51.
Discussion
Chemical abundance in biosolids should be interpreted as a multi-
faceted, cumulative proxy to the (i) current rate of chemical usage,
(ii) resistance to biotransformation, and (iii) partitioning behavior
www.nature.com/scientificreports
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(and thus bioaccumulation potential) as shown in this study. The
present work explored the new approach of using biosolids as an
analytical matrix to identify potentially harmful, mass-produced
chemicals of human health concern. Admittedly, the 231 CECs
investigated here represent only a modest sample of the tens of
thousands of potential CECs present inmodern society. By necessity,
the current approach was limited to compounds for which analytical
methods were readily available. Future work will be required to
extend this effort to include other CECs, and to identify a much
wider range of mass-produced priority chemicals, their byproducts
and transformation products. Use of gas chromatography-mass
spectrometry in scan mode followed by spectral analysis using data-
base searches may aid in this chemical discovery process.
Additionally, chemicals sequestered in biosolids may serve as an
early warning system for determining potential bioaccumulative che-
micals and chemical body burdens in population. This ‘pre-screen-
ing’ step effectively can reduce the several thousands of known or
suspected hydrophobic CECs to a manageable list of priority chemi-
cals. Furthermore, it also can serve to conveniently screen experi-
mentally for transformation products of man-made and natural
compounds which likely are persistent and bioaccumulative but
for which production and environmental loading data are unavail-
able. From the present study, we infer that the eight compounds
falling into the ‘‘most abundant’’ category have to be considered
priority contaminant candidates from a public health perspective,
deserving scrutiny with respect to their potential for exposure, bioac-
cumulation and potential adverse health effects in biota, including
humans. While the screening approach presented here provides
important insights into the abundance and bioaccumulation poten-
tial of chemicals, it does not inform on chemical toxicity, which is
critical for risk assessment of chemicals. Hence, for a comprehensive
risk screening, chemicals emerging as a priority contaminant can-
didate from the present screening approach should further be eval-
uated with expert knowledge of their absorption, distribution,
metabolism, and excretion (ADME) and their potential toxicity to
humans and ecosystems.
Overall, the approach presented here was found to be in concord-
ance with results of prior risk prioritization approaches6,7 while also
offering insights into current chemical consumption rates. An inter-
esting correlation was found between chemicals that bioaccumulate
in humans and those that persist during wastewater treatment and
accumulate in sludge (Fig. 4b). Such a correlation intrinsically is
vulnerable to sample bias, however. Therefore, future work is needed
to further validate and carefully define the limits of the chemical
prioritization approach presented here.
Methods
Sample description. Biosolids samples analyzed in the present study were originally
collected by U.S. EPA as part of the 2001 National Sewage Sludge Survey (NSSS). After
completion of 2001 NSSS, the samples were acquired by our laboratory and stored in
amber glass jars (500 mL) at 220uC for further analysis. The facilities were selected by
the U.S. EPA to obtain unbiased national estimates of chemical contaminants in U.S.
sewage sludges that are disposed of primarily by land application. The samples were
collected between February and March 2001 according to an established protocol, only
from facilities that included secondary treatment. Representative samples were
collected in 500 mL glass or polyethylene jars from 94 WWTPs in 32 U.S. States and
the District of Columbia. Information on specific sampling locations is available in the
peer-reviewed literature11. Samples were collected only from processed sewage sludges
intended for disposal. The biosolids composites analyzed in this study constitute a
representative sample (94 facilities) of the more than 16,000 U.S. WWTPs. Of the 94
WWTPs, 89 had single system (either aerobic or anaerobic digestion) and five of them
had two systems for sludge treatment (both aerobic and anaerobic digestion). Samples
were collected from each treatment systems amounting to a total of 113 biosolids
samples. Three of these samples were excluded from analysis due to broken containers.
The rest of the 110 biosolids samples were randomly grouped into five composite
samples, each containing solids from between 21 and 24 individual samples. Sampling
procedure and preparation of composites are described in detail elsewhere11. A
duplicate of composite sample #1 was prepared to serve as a blind duplicate. Composite
samples were prepared to establish national baseline levels for these compounds; the
validity of the present approach has been demonstrated previously11,15–17.
Sample analysis. The samples were analyzed by a commercial lab (AXYS Analytical
Services Ltd., Sydney, British Columbia, Canada) that developed EPAMethod 1694 for
pharmaceuticals and personal care products, and that specializes in the analysis of
traditional and emerging contaminants. AXYS is a nationally accredited commercial
lab in Canada and also is accredited by the National Environmental Laboratory Accredi-
tation Program (NELAC) in Florida and New Jersey. The biosolids composites were
analyzed for pharmaceuticals and personal care products (PPCPs), alkylphenols and
their ethoxylates (AP and APEOs), brominated flame retardants (BFRs), perfluorinated
compounds (PFCs), brominated dioxins and furans (Br-D/F), hormones and sterols.
The concentrations were determined by isotope dilution for compounds with available
labeled analog. Concentrations of compounds without a labeled analogwere determined
by external calibration. All concentrations are reported on a dry weight (dw) basis.
Analytes were extracted and analyzed for each group of compounds as follows:
PPCPs. Samples were analyzed according to AXYS Method MLA – 075, a modi-
fication of U.S. EPA Method 1694. For the purpose of compound detection, the 120
analytes were divided into five groups. All analytes were separated by liquid chro-
matography and detected by tandem mass spectrometry (LC-MS/MS) (see
Supplementary Table S1 online). List 1–3 and 5 were extracted at a pH 2.0 (acid
extraction), while fourteen analytes in list 4 required basic extraction at pH 10. Prior
to extraction, 1 g of dried samples were adjusted to the required pH and spiked with
surrogates/labeled analogs. Solid samples were extracted by sonication with aceto-
nitrile, concentrated by rotary evaporation, and diluted with ultra pure water to
200 mL. The extracts were then filtered, cleaned up by solid phase extraction (SPE),
and analyzed by LC-MS/MS in positive and negative modes. Lists 1, 2, 4 and 5 were
analyzed in positive electro-spray ionization (ESI) mode, whereas List 3 was analyzed
in negative ESI mode (EPA Method 1694; EPA-821-R-08-002). Detailed analysis
procedures and method performance are described elsewhere15.
AP and APEOs. The samples were base digested and liquid-liquid extracted with
hexane followed by non-aqueous acetylation. Derivitized extracts were then cleaned
Figure 4 | (a) Comparison of organic chemicals detected in biosolids (from present study and EPA’s national sludge survey together) and in human
samples from the national report on human exposure to environmental chemicals study by CDC, representing the U.S. population. The hashed portion
represents the common chemicals detected in both biosolids and humans. (b) Comparison of lipid-normalized concentration of the 34 chemicals
detected in human serum and biosolids samples. Analytes with available geometric mean concentrations in human serum were compared with mean
concentrations detected in biosolids. For analytes with unavailable mean concentration in human serum, 95th percentile values were compared.
www.nature.com/scientificreports
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up using a 5% silica chromatography column. A recovery standard was added prior to
analysis. Instrumental analysis was performed on a RTX-5 capillary gas chromato-
graphy column coupled to a low-resolution mass spectrometer (LRMS) (see
Supplementary Table S2 online). The LRMS was operated in electron ionization (EI)
mode using multiple ion detection (MID) acquiring at least 2 characteristic ions for
each target analyte and surrogate standard. Detailed analysis procedures and method
performance are described elsewhere16.
BFR. A selected suite of brominated diphenylethers (BDEs) were analyzed according
to the protocol described in EPAMethod 1614. Samples were spiked with isotopically
labeled BDE surrogate standards, solvent extracted, spiked with a cleanup surrogate
standard and cleaned up on a series of chromatographic columns that included
layered acid/base silica, Florisil and alumina columns. The final extract was spiked
with isotopically labeled internal standards prior to instrumental analysis. Analysis of
BDEwas performed using a capillary gas chromatograph coupled to a high resolution
mass spectrometer (HRMS). A DB-5HT capillary column (30 m, 0.25 mm i.d. 3
0.1 mm film thickness) was coupled to theMS source. Twomasses from themolecular
ion cluster were used to monitor each of the target analytes (EPAMethod 1614; EPA-
821-R-07-005). Non-BDE BFRs were analyzed by the same method by introducing
additional native, labeled surrogates, and calibration standard solutions (see
Supplementary Table S3 online).
For polybrominated biphenyl analysis (PBB), about 1 g (dry) of sample was spiked
with 13C-labeled polychlorinated biphenyl (PCB) quantification standards and
Soxhlet extracted with dichloromethane. The extracts were cleaned up using Florisil
columns. The final extracts were concentrated and spiked with recovery standards
prior to analysis by high performance liquidchromatography/tandem mass spectro-
metry (HRGC/HRMS) (see Supplementary Table S4 online).
For hexabromocyclododecane (HBCDD) analysis, about 1.5 g (dry) sample was
spiked with 13C-labelled surrogate standards and Soxhlet extracted with dichloro-
methane. The extracts were cleaned up using Florisil column. The final extracts were
concentrated and spiked with recovery standards prior to analysis by high per-
formance liquid chromatography/tandem mass spectrometry (HPLC/MS-MS) (see
Supplementary Table S5 online).
PFCs. About 5 g of dried samples were spiked with isotope-labeled surrogates and
analytes were extracted by shaking initially with dilute acetic acid solution and then
twice with methanolic ammonium hydroxide solution, each time collecting the
supernatants. The supernatants were combined and treated with ultra pure carbon
powder. The resulting solution was diluted with water and cleaned up by SPE. The
eluate was then spiked with recovery standards prior to analysis. The sample extract
was then separated by high performance liquid chromatography reversed phase C18
column using a solvent gradient. The columnwas coupled to a triple quadrupolemass
spectrometer in Multiple Reaction Monitoring (MRM) mode (see Supplementary
Table S6 online). Detailed analysis procedures and method performance are
described elsewhere17.
Br-D/F. Samples were spiked with isotope labeled surrogate standards, dried with
sodium sulphate followed by Soxhlet extraction in toluene/acetone. The crude
extracts were then cleaned by column chromatography on a layered acid/base silica
column. The extract was then spiked with isotope-labeled internal standards and
analyzed by capillary gas chromatography/high resolution mass spectrometry (GC/
HRMS). A DB-5HT capillary column was used for separation. Two masses from the
molecular ion cluster were used to monitor each of the target analytes (see
Supplementary Table S7 online).
Sterols and hormones. About 1 g of dried samples was acidified to pH 2 and spiked
with surrogate standards. The sample was then extracted by sonication with aqueous
buffered acetonitrile and with pure acetonitrile, concentrated by rotary evaporation,
and diluted with ultra pure water to 200 mL. The extracts were then cleaned up by
SPE. After addition of recovery standards, the cleaned extracts were analyzed by high
performance liquid chromatography coupled to a triple quadrupole mass spectro-
meter. The analysis was run in MRM mode in both positive and negative ESI mode
(see Supplementary Table S8 online).
Quality assurance. Several tests were performed before sample analysis to ensure
system and laboratory performance. A calibration standard solution with labeled and
native analytes was used to verify calibration accuracy. Retention times of the analytes
had to be within 615 seconds of the respective retention time established during the
previous calibration. Lab blanks were analyzed before each sample. Duplicate analysis
was performed for each batch with more than six samples. To evaluate analysis
precision, a blind duplicate was included in the sample set.
Modeling annual load of chemicals in biosolids.Annual load was determined for all
detected analytes based on the annual biosolids production of 5.1–6.4 million metric
dry tonnes (5.6–7 million dry U.S. tons) estimated for the year 2001 in the U.S.
(Supplementary Table S9)52–54.
[Annual load5 (chemical concentration in biosolids) mg/kg * (1029 kg/mg) * (5.1–
6.4 3 109 kg of biosolids/year)]
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